These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12131021)

  • 21. Slowed ST segment recovery despite early infarct artery patency in patients with Q waves at presentation with a first acute myocardial infarction. Implications of initial Q waves on myocyte reperfusion.
    Wong CK; French JK; Krucoff MW; Gao W; Aylward PE; White HD
    Eur Heart J; 2002 Sep; 23(18):1449-55. PubMed ID: 12208225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombolysis and Q wave versus non-Q wave first acute myocardial infarction: a GUSTO-I substudy. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries Investigators.
    Barbagelata A; Califf RM; Sgarbossa EB; Goodman SG; Stebbins AL; Granger CB; Suarez LD; Borruel M; Gates K; Starr S; Wagner GS
    J Am Coll Cardiol; 1997 Mar; 29(4):770-7. PubMed ID: 9091523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relative contributions of a single-admission 12-lead electrocardiogram and early 24-hour continuous electrocardiographic monitoring for early risk stratification in patients with unstable coronary artery disease.
    Holmvang L; Andersen K; Dellborg M; Clemmensen P; Wagner G; Grande P; Abrahamsson P
    Am J Cardiol; 1999 Mar; 83(5):667-74. PubMed ID: 10080416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Long-term follow-up of patients with acute myocardial infarction treated with primary angioplasty or thrombolysis. Results of the MITRA trial].
    Zhan R; Schiele R; Schneider S; Gitt AK; Heer T; Wienbergen H; Seidl K; Glunz HG; Hauptmann KE; Voigtländer T; Gottwik M; Senges J;
    Z Kardiol; 2002 Jan; 91(1):49-57. PubMed ID: 11963207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic implications of TIMI flow grade in the infarct related artery compared with continuous 12-lead ST-segment resolution analysis. Reexamining the "gold standard" for myocardial reperfusion assessment.
    Shah A; Wagner GS; Granger CB; O'Connor CM; Green CL; Trollinger KM; Califf RM; Krucoff MW
    J Am Coll Cardiol; 2000 Mar; 35(3):666-72. PubMed ID: 10716469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuous ST segment recording during thrombolysis in acute myocardial infarction: a report on orthogonal ECG monitoring.
    Badir BF; Nasmith JB; Dutoy JL; Dubé B; Cardinal R; LeBlanc AR; Nadeau R
    Can J Cardiol; 1995; 11(7):545-52. PubMed ID: 7656190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early ST-segment recovery, infarct artery blood flow, and long-term outcome after acute myocardial infarction.
    French JK; Andrews J; Manda SO; Stewart RA; McTigue JJ; White HD
    Am Heart J; 2002 Feb; 143(2):265-71. PubMed ID: 11835029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-Q-wave versus Q-wave myocardial infarction after thrombolytic therapy: angiographic and prognostic insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries-I angiographic substudy. GUSTO-I Angiographic Investigators.
    Goodman SG; Langer A; Ross AM; Wildermann NM; Barbagelata A; Sgarbossa EB; Wagner GS; Granger CB; Califf RM; Topol EJ; Simoons ML; Armstrong PW
    Circulation; 1998 Feb; 97(5):444-50. PubMed ID: 9490238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Streptokinase antibodies inhibit reperfusion during thrombolytic therapy with streptokinase in acute myocardial infarction.
    Juhlin P; Boström PA; Torp A; Bredberg A
    J Intern Med; 1999 May; 245(5):483-8. PubMed ID: 10363749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of long-term outcome by the extent of existing ST-segment deviation in a single electrocardiographic lead shortly after thrombolysis in acute myocardial infarction.
    Schröder K; Wegscheider K; Zeymer U; Schröder R
    Am J Cardiol; 2003 Feb; 91(4):454-7. PubMed ID: 12586265
    [No Abstract]   [Full Text] [Related]  

  • 31. Prognostic value of clinical markers of reperfusion in patients with acute myocardial infarction treated by thrombolytic therapy.
    Pomés Iparraguirre H; Conti C; Grancelli H; Ohman EM; Calandrelli M; Volman S; Garber V
    Am Heart J; 1997 Oct; 134(4):631-8. PubMed ID: 9351729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of the electrocardiogram on the delivery of thrombolytic therapy for acute myocardial infarction.
    Sharkey SW; Berger CR; Brunette DD; Henry TD
    Am J Cardiol; 1994 Mar; 73(8):550-3. PubMed ID: 8147299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of streptokinase, but not tissue-type plasminogen activator, in achieving 90-minute patency after thrombolysis for acute myocardial infarction decreases with time to treatment. PERM Study Group. Prospective Evaluation of Reperfusion Markers.
    Steg PG; Laperche T; Golmard JL; Juliard JM; Benamer H; Himbert D; Aubry P
    J Am Coll Cardiol; 1998 Mar; 31(4):776-9. PubMed ID: 9525545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rescue thrombolysis: alteplase as adjuvant treatment after streptokinase in acute myocardial infarction.
    Mounsey JP; Skinner JS; Hawkins T; MacDermott AF; Furniss SS; Adams PC; Kesteven PJ; Reid DS
    Br Heart J; 1995 Oct; 74(4):348-53. PubMed ID: 7488444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inverse relation between diastolic blood pressure and long-term outcomes in patients undergoing pharmacoinvasive therapy for myocardial infarction: the J-shaped relation in the contemporary era of revascularisation.
    Lee CH; Foo D; Wong HB; Hong EC; Seow SC; Ng KS; Lim YT; Tan HC
    J Cardiovasc Med (Hagerstown); 2006 Nov; 7(11):806-11. PubMed ID: 17060806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low molecular weight heparin (dalteparin) as adjuvant treatment of thrombolysis in acute myocardial infarction--a pilot study: biochemical markers in acute coronary syndromes (BIOMACS II).
    Frostfeldt G; Ahlberg G; Gustafsson G; Helmius G; Lindahl B; Nygren A; Siegbahn A; Swahn E; Venge P; Wallentin L
    J Am Coll Cardiol; 1999 Mar; 33(3):627-33. PubMed ID: 10080461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term survival in 618 patients from the Western Washington Streptokinase in Myocardial Infarction trials.
    Cerqueira MD; Maynard C; Ritchie JL; Davis KB; Kennedy JW
    J Am Coll Cardiol; 1992 Dec; 20(7):1452-9. PubMed ID: 1452917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators.
    Simes RJ; Topol EJ; Holmes DR; White HD; Rutsch WR; Vahanian A; Simoons ML; Morris D; Betriu A; Califf RM
    Circulation; 1995 Apr; 91(7):1923-8. PubMed ID: 7895348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Left ventricular function and cardiovascular events following adjuvant therapy with adenosine in acute myocardial infarction treated with thrombolysis, results of the ATTenuation by Adenosine of Cardiac Complications (ATTACC) study.
    Quintana M; Hjemdahl P; Sollevi A; Kahan T; Edner M; Rehnqvist N; Swahn E; Kjerr AC; Näsman P;
    Eur J Clin Pharmacol; 2003 May; 59(1):1-9. PubMed ID: 12743668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improvement in long-term prognosis of elderly patients with acute myocardial infarction after the introduction of intravenous thrombolytic therapy.
    Madsen JK; Pedersen F; Nielsen H; Jensen GV; Hansen JF
    Scand Cardiovasc J; 1998; 32(6):365-70. PubMed ID: 9862099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.